According to Adial Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is $15.50. In 2022 the company made an earnings per share (EPS) of -$108.00 a decrease over its 2021 EPS that were of -$26.25.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $15.50 | -114.35% |
2022 | -$108.00 | 311.43% |
2021 | -$26.25 | 22.09% |
2020 | -$21.50 | -4.44% |
2019 | -$22.50 | -50.18% |
2018 | -$45.16 | 721.75% |
2017 | -$5.50 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Nymox Pharmaceutical NYMX | -$0.06000 | -100.39% | Bahamas |
NRC Health
NRC | $1.19 | -92.32% | ๐บ๐ธ USA |